Facebook
X
LinkedIn
Forward| Title | Credit | Series date |
Member price |
Non-member price |
|---|---|---|---|---|
|
JPHC CE: The Resurgence of Syphilis: A Critical Public Health Concern 1.25 NAPNAP contact hour of which 0.5 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Syphilis, a sexually transmitted infection caused by Treponema pallidum, has become a concerning resurgence in recent years, particularly in the United States. Of significant concern is the steep rise in congenital syphilis cases, which poses grave risks to maternal and neonatal health. This article provides an overview of the epidemiology, risk factors, clinical manifestations, screening methods, and treatment strategies for syphilis, with a specific focus on congenital transmission. Drawing upon current literature and guidelines, the paper underscores the importance of early detection and intervention to prevent adverse outcomes associated with congenital syphilis. Furthermore, the article highlights the challenges in syphilis diagnosis, including the interpretation of serological tests and the management of neurosyphilis. Recommendations for practice, including screening protocols and treatment regimens, are discussed in detail. The conclusion emphasizes the urgent need for collaborative efforts among healthcare providers, public health agencies, and community stakeholders to address the syphilis epidemic effectively. By adhering to evidence-based guidelines and leveraging available resources, clinicians can play a pivotal role in reducing the burden of syphilis and safeguarding the health of vulnerable populations, particularly pregnant women and infants. J Pediatr Health Care. (2025) 39, 479-488. |
|
05/01/2025 to 06/30/2026 | $0.00 | $10.00 |
|
Hidden in Plain Sight: Uncovering Cytomegalovirus (CMV) for the Pediatric NP 0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and non-members. |
|
02/17/2025 to 01/31/2027 | $0.00 | $0.00 |
|
Emerging Health Threats in Infants: Perinatal Hepatitis C 0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and non-members. Emerging Health Threats in Infants: Perinatal Hepatitis C. |
|
02/17/2025 to 01/31/2027 | $0.00 | $0.00 |
|
JPHC CE: Diagnosis and Management of Pediatric Allergic Rhinoconjunctivitis in the US 1.0 NAPNAP contact hour of which 0.5 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Allergic rhinoconjunctivitis (AR/C) is a common pediatric condition. The physical, emotional, and social burden of AR/C in children highlights the need for accurate diagnosis with optimal treatment. This review provides practical information on the diagnosis and management of pediatric AR/C. Key features of the patient history and physical exam needed to diagnose seasonal and perennial AR/C are covered. Various AR/C treatment options are reviewed such as allergen avoidance, pharmacotherapies, and allergy immunotherapy (both subcutaneous injections and sublingual tablets) as well as their mode of action, side effects, and their role in guideline-recommended therapy. Practical information such as pollen calendars, management algorithms, and treatment product characteristics have also been included in this review. J Pediatr Health Care. (2025) 39, 489-502. |
|
05/01/2025 to 06/30/2026 | $0.00 | $10.00 |
|
JPHC CE: The Landscape of Substance Use in Youth-2024 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. An essential role of pediatric providers is to counsel youth and parents on behavioral health issues, including the use of Alcohol or other drugs (AODs). Although substance use by adolescents has decreased, a significant number of adolescents use AODs, causing those with regular use to be at risk of developing behavioral, physical, and mental health consequences that can continue into adulthood. This article was written to help pediatric providers understand the scope and associated effects of AOD use in their adolescent patients and equip them to counsel, identify, and intervene to reduce the harm to their patients who use AODs. J Pediatr Health Care (2025) Issue 6, p1-12. |
|
11/01/2025 to 12/31/2026 | $0.00 | $10.00 |
|
Tick Talk: Digging Deeper into Lyme Disease 2024 1.0 NAPNAP Contact Hour. This continuing education activity is free to National Association of Pediatric Nurse Practitioners (NAPNAP) members and non-members. This course is a recorded presentation for NAPNAP's 2024 National Conference. Lyme disease is the most common vector-borne disease in the U.S., with a childhood peak at five to nine years of age. Pediatric-focused APRNs in both high and low incidence areas may encounter patients in whom Lyme disease is a concern. This presentation will provide an in-depth review of Lyme disease testing and interpretation, discuss when (and when not) to treat and examine the current knowledge regarding prolonged symptoms. |
|
06/27/2024 to 06/30/2026 | $0.00 | $0.00 |
|
JPHC CE: Trauma Exposure in Migrant Children: Implications for Mental and Physical Health 1.5 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Global migration is a public health crisis of epidemic proportions. Migrants are at risk for a variety of physical and mental health concerns, while having limited access to healthcare. Migrant children are especially vulnerable to experiencing significant trauma, both physical and emotional. Children comprise less than one third of the global population, yet nearly half of migrants are children less than 18 years of age. The United States is home to a significant number of migrant children. Migrant children have a unique set of educational, health, and emotional needs. Given the sheer number of migrant children living in the U.S., pediatric nurse practitioners (PNP) must understand their unique needs and provide evidence-based interventions to help meet these needs. This continuing education article will discuss migrant children in terms of understanding migration, trauma exposure and resultant impact on psychological and physical health, and implications for practice. J Pediatr Health Care (2025) 40, 1-12. |
|
09/01/2025 to 10/31/2026 | $0.00 | $10.00 |
|
Emerging Health Threats in Infants: Congenital Syphilis 0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and non-members. Emerging Health Threats in Infants: Congenital Syphilis |
|
04/08/2025 to 04/30/2027 | $0.00 | $0.00 |
|
JPHC CE: Patellofemoral Pain Syndrome in Adolescents: Continuing Education for the Primary Care Provider 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Patellofemoral Pain Syndrome (PFPS) is a multifactorial complaint of anterior knee pain. Patellofemoral pain typically spreads diffusely across the knee, is notable during weight bearing, and is exacerbated by knee flexion. Patellofemoral pain is often insidious in onset, typically with no identifiable mechanism of injury. Factors believed to contribute to PFPS include overuse, muscular imbalance, joint malalignment, and, rarely, trauma to the joint (Bump & Lewis, 2023). J Pediatr Health Care (2025) 39, 686-694. |
|
07/01/2025 to 08/31/2026 | $0.00 | $10.00 |
|
JPHC CE: Preventing HIV in the Adolescent Population with PrEP: The Role of the Nurse Practitioner 1.0 NAPNAP contact hour of which 1.0 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Preexposure prophylaxis (PrEP) uptake remains low among adolescents and young adults at high risk due to various barriers, such as decreased access to care, human immunodeficiency virus (HIV) stigma, and misinformation. The barriers to the uptake of PrEP among adolescents and young adults are multifaceted and require comprehensive mitigation strategies. Presented is the epidemiology of HIV, pathophysiology, and complications of HIV in adolescents, history of PrEP research, “How to End the HIV Epidemic in the U.S.” plan, reviewing and eliminating barriers to PrEPcare, PrEP curriculum opportunities for the provider, and the role of the nurse practitioner in reducing new HIV diagnoses in adolescents. J pediatr Health Care. (2025) 39, 503−514. |
|
05/01/2025 to 06/30/2026 | $0.00 | $10.00 |
|
2025 Pediatric Pharmacology Update 1.00 NAPNAP Contact Hour of which 1.00 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. A fast-paced update on pediatric prescribing including newly approved or relabeled pediatric medications, and pediatric pharmacology studies in process. Issues that affect pediatric practice including drug shortages, emerging poisoning hazards, and new guidelines will be discussed. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
Pharmacologic Management of Cardiac Dysrhythmias 1.25 NAPNAP Contact Hour of which 1.25 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. This presentation will focus on the treatment of common dysrhythmias seen in children, specifically pharmacologic options. We will review both inpatient and outpatient management of various dysrhythmias. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
2025 Psychopharmacology Update 2.75 NAPNAP Contact Hour of which 2.75 pharmacology content, 2.75 are Psychopharmacology content and 0.25 are Controlled Substance content. This archived presentation from our 2025 national conference is available only as part of a bundle of pharmacology courses recorded during our 2025 conference in Chicago. Purchase the 2025 Pediatric Pharmacology Bundle and gain access to all five courses. Children and adolescents with behavioral health conditions are commonly seen in all pediatric environments. We will focus on the emerging use of long-acting formulations for management of chronic psychiatric conditions and other new pharmacologic approaches to behavioral health management. This presentation is solely focused on pharmacology and aims to help demystify these medications for the pediatric provider. NAPNAP’s Developmental Behavioral and Mental Health SIG is pleased to support this session. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
Navigating the Transition: Supporting Youth Aging Out of Foster Care 0.75 NAPNAP Contact Hour. This continuing education activity is offered for free to NAPNAP Members until 1/31/2026. For non-members, this continuing education activity rate is $15. Youth "age out" of foster care when they reach the legal age of emancipation, typically 18 in most states, though some states extend this to 21. The transition from foster care to independent adulthood can be particularly challenging, often marked by limited resources, social isolation, and a lack of access to essential support systems. |
|
04/28/2025 to 04/30/2027 | $0.00 | $15.00 |
|
Keeping Current in Atopic Diseases 1.25 NAPNAP Contact Hour of which 1.25 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. The field of Allergy & Immunology continues to expand and incorporate new therapeutics to manage difficult diseases. In 2024, new drugs have been approved that can revolutionize treatment for disease management. Patients will look to their primary care clinicians to be knowledgeable and a resource for these therapeutics. This panel will include three NP experts from food allergy centers at the Children’s Hospital of Philadelphia and University of Texas Southwestern and will discuss biologics, immunotherapy options and non-IgE mediated disease updates for food allergy. NAPNAP’s Asthma and Allergy SIG is pleased to support this session. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |